Navigation Links
Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference
Date:7/27/2011

ATLANTA, July 27, 2011 /PRNewswire/ -- Vystar® Corporation (OTCBB: VYST), creators of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins and other non-rubber particles found in natural rubber latex, will present a technical paper at the 13th International Latex Conference (ILC) on July 27, 2011 titled "Further Development of Vytex® Natural Rubber Latex Leads to Strong Niche Market Advances."  Matt Clark, Vystar's Vice President of Technical Sales, will address attendees at the ILC, and will present with leaders in the latex industry such as R. T. Vanderbilt Co. Inc., Kraton Innovation Center, BASF, and distinguished chemistry education centers such as Penn State University and The Ohio State University.

The paper notes that Vytex NRL has proven to be a versatile material offering numerous advantages across a broad variety of applications.  Vytex is currently used in the production of finished goods from high-end jewel tone balloons that are brighter and retain air better, to low-odor foams for pillows and mattresses, low-protein adhesives with superior adhesion properties, and condoms and gloves that have received FDA 510(k) clearance.  The low non-rubber properties comply with the new ASTM D1076-10 category 5 classification, and as a result of the cleaner material properties, use of Vytex NRL can help dipped goods producers increase their product quality as well as reduce water and energy consumption by eliminating the need for additional leaching steps to reduce protein levels. To read the paper in its entirety, please visit the following link:

http://bit.ly/riQyQ0

Bill Doyle, Chairman and Chief Executive Officer, commented: "This presentation highlights Vytex's proven versatility and numerous advantages across a broad range of applications.  Our goal through giving these presentations is to educate our peers on the unique characteristics of Vytex and how our specific research and development of specialized versions of this unique raw material can help our customers meet their product diversification challenges while reducing production costs. The International Latex Conference provides a strong platform to present the latest in latex technology, and we are pleased to be presenting among the foremost thought leaders in the industry. I would also like to make a special acknowledgement of Travis Honeycutt, our founder and inventor of Vytex NRL, who co-authored this paper and continues to work with Vystar on special projects."  

About Vystar Corporation

Based in Duluth, GA, Vystar ® Corporation (OTC Bulletin Board: VYST) is the exclusive creator of Vytex Natural Rubber Latex (Vytex NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of antigenic proteins and other non-rubber particles found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products to bring Vytex NRL to market in adhesives, balloons, surgical and exam gloves, other medical devices and natural rubber latex foam mattresses, pillows and sponges.  For more information, visit www.vytex.com.

Forward-looking Statements: Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.  Actual results may differ materially from those included in these statements due to a variety of factors. Furthermore, the proposed merger discussed herein may not be completed. More information about these factors is contained in Vystar's filings with the Securities and Exchange Commission.

Contact:
The Investor Relations Group
11 Stone St. 3rd Floor
New York, NY
212-825-3210

IR: Adam Holdsworth
PR: Laura Colontrelle/Janet Vasquez

Vystar Corporation
Jack Callicutt, Chief Financial Officer
770-965-0383 x23


'/>"/>
SOURCE Vystar Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing
2. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
3. CVS Caremark Corporation to Hold Second Quarter 2011 Conference Call
4. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
5. Biomerix Corporation and Gel Company Announce Strategic Distribution Agreement
6. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
7. QuantRx Biomedical Corporation Provides Corporate Update
8. American Scientific Resources and School Health Corporation to Supply The Disintegrator™ Needle Destruction Device to Texas School District
9. China Medicine Corporation to Restate Financial Statements for 2006 and 2007
10. CVS Caremark Corporation Announces Quarterly Dividend
11. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... Sanovas, Inc., a life science asset holding company ... wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed Intubation ... http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed annually ...
(Date:12/5/2016)... WOONSOCKET, R.I. , Dec. 5, 2016 /PRNewswire/ ... CVS ) Research Institute and the U.S. ... the Assistant Secretary for Preparedness and Response (ASPR), ... showed that automated pharmacy notifications encourage patients ... a forecasted natural disaster. The study also affirms ...
Breaking Medicine Technology:
(Date:12/5/2016)... Diego, CA (PRWEB) , ... December 05, 2016 , ... ... seen and heard the dangers and downsides of patients who do not do their ... The field of cosmetic dermatology is in the midst of a renaissance and every ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
Breaking Medicine News(10 mins):